why choose us

First received: October 06, 2023

Clinical Trial: Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Relapsed/Refractory Large B-cell Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Open-label, Single Arm, Multicenter Study Evaluating the Safety and Efficacy of KITE-197 in Subjects With Relapsed or Refractory Large B-cell Lymphoma

Brief Summary: This study will have two Phases: Phase 1a and Phase 1b.The goal of Phase 1a of this clinical study is to learn more about the safety, tolerability and dosing of study drug KITE-197, in participants with relapsed or refractory large B-cell lymphoma (r/rLBCL).The goal of Phase 1b of this clinical study is learn about the effectiveness of the recommended dose of KITE-197 in participants with r/r LBCL.The primary objectives of this study are:Phase 1a: To evaluate the safety of KITE-197 in participants with…

Read more